The onset of type 2 diabetes increases the risk of vascular complications and death. We know now that that this risk begins long before the diabetes diagnosis. Prediabetes and type 2 diabetes are not separate entities in practice and exist within a continuum of dysglycaemia and vascular risk that increases in severity over time. This excess risk requires early intervention with lifestyle therapy supported with pharmacologic antidiabetic therapy, intensified promptly where necessary throughout the duration of the diabetes continuum. Metformin is an evidence-based treatment for preventing prediabetes and improves cardiovascular outcomes in people with type 2 diabetes from diagnosis onwards. Newer agents (SGLT2 inhibitors and GLP-1 agonists) are appropriate for people presenting with type 2 diabetes and significant cardiovascular comorbidity. Additional therapies should be used without delay to achieve patients’ individualised HbA1c goals and to minimise cardiovascular risk.
ConclusionThe IF diet is an efficient dietary plan for those aiming at a weight loss journey over a short duration, ranging from less than a month up to three months. Minimal side effects were found during fasting, being of different intensities, which did not need surgical or medical treatment. All in all, most of our respondents were pleased with their experience and saw excellent weight loss results using the IF diet.
Introduction: The ketogenic diet has been in use since the 1920s as a therapy for epilepsy. Since the 1960s, it has also become widely known as one of the methods for obesity treatment. Recently, this diet has been promoted as a lifestyle, making it highly controversial in terms of its practicality as a lifestyle diet and its duration without affecting one's health or quality of life. Hence, this study assessed ketogenic diets from the people's perspective of side effects, attitude, and quality of life.Method: This retrospective observational study evaluated people who experienced or still practice a ketogenic diet. Health-related quality of life, the standard four-item set of healthy days core questions, was employed. We distributed the survey as an electronic self-assessment using Google Forms. The data were reviewed and automatically copied into a personal computer, arranged in a data-sheet in Microsoft Excel, and analyzed using Statistical Package for the Social Sciences version 27 (Armonk, NY: IBM Corp.). The data were mainly expressed as numbers and percentages.Results: A total of 226 subjects who adopted a ketogenic diet were interviewed to explore their diet experience. Females were slightly more than males (52.7% vs. 47.3%), and more than one-half (55.3%) of this study population aged 18-35 years. Obesity accounted for 55.3%, and the majority of the respondents (69.9%) adopted a ketogenic diet for more than one month. Among the most frequently reported symptoms were nausea (mild, 29.2%; moderate, 16.4%; severe nausea, 5.8%), dizziness (mild, 39.8%; moderate, 27.4%; severe, 11.5%), polyuria (72.1% in total), and lethargy (69.7%). Furthermore, 90.3% of them felt happy about adopting a ketogenic diet, and 81.9% would recommend it for anyone who wants to lose weight. Conclusion: A ketogenic diet was practiced mostly for one to six months, making it a short-term solution to weight loss. The outcomes of the participants approved the efficacy of the ketogenic diet in weight reduction. Different symptoms and side effects occurred with varying intensities, especially in the first few days of adopting this diet. Overall, the ketogenic diet did not affect the quality of life and yielded a very positive overall experience.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.